Back to search

Treatment of poor-prognosis early rheumatoid arthritis: A randomized study of treatment with methotrexate, cyclosporin A, and intraarticular corticosteroids compared with sulfasalazine alone

Data up to Jan 2025

Published2000
Citations135
References43
Clinical Trials (1)

Total Citations Per Year

Abstract

References (43)

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

1988 • 19,632 citations

Revised Criteria for the Classification of Rheumatoid Arthritis

1990 • 7,730 citations

Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritis

1995 • 5,929 citations

American college of rheumatology preliminary definition of improvement in rheumatoid arthritis

1995 • 2,778 citations

How to read radiographs according to the Sharp/van der Heijde method.

1999 • 1,127 citations

Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis

1997 • 1,087 citations

Preliminary criteria for clinical remission in rheumatoid arthritis

1981 • 806 citations

The Effect of Glucocorticoids on Joint Destruction in Rheumatoid Arthritis

1995 • 804 citations

Generalised bone loss in patients with early rheumatoid arthritis

1994 • 628 citations

Combination Therapy with Cyclosporine and Methotrexate in Severe Rheumatoid Arthritis

1995 • 530 citations

The Effectiveness of Early Treatment with “Second-Line” Antirheumatic Drugs

1996 • 465 citations

Induction of Interleukin 2 Messenger RNA Inhibited by Cyclosporin A

1984 • 404 citations

Patients with rheumatoid arthritis benefit from early 2nd line therapy: 5 year followup of a prospective double blind placebo controlled study.

1995 • 316 citations

Rheumatism in populations

1977 • 297 citations

PROGNOSTIC FACTORS FOR RADIOGRAPHIC DAMAGE AND PHYSICAL DISABILITY IN EARLY RHEUMATOID ARTHRITIS. A PROSPECTIVE FOLLOW-UP STUDY OF 147 PATIENTS

1992 • 288 citations

Molecular therapeutics. Methotrexate and its mechanism of action

1996 • 266 citations

Gene Expression (Collagenase, Tissue Inhibitor of Metalloproteinases, Complement, and HLA–DR) in Rheumatoid Arthritis and Osteoarthritis Synovium. Quantitative Analysis and Effect of Intraarticular Corticosteroids

1991 • 262 citations

Joint destruction after glucocorticoids are withdrawn in early rheumatoid arthritis. Arthritis and Rheumatism Council Low Dose Glucocorticoid Study Group

1998 • 207 citations

Early effective suppression of inflammation in rheumatoid arthritis reduces radiographic progression

1998 • 185 citations

The Acute-Phase Response in Relation to Radiographic Progression in Early Rheumatoid Arthritis: A Prospective Study During the First Three Years of the Disease

1993 • 165 citations

The acute phase and function in early rheumatoid arthritis. C-reactive protein levels correlate with functional outcome.

1997 • 164 citations

Randomised placebo-controlled study of stopping second-line drugs in rheumatoid arthritis

1996 • 154 citations

Methotrexate reduces inflammatory cell numbers, expression of monokines and of adhesion molecules in synovial tissue of patients with rheumatoid arthritis

1998 • 139 citations

IMMUNOHISTOLOGICAL FEATURES IN THE SYNOVIUM OBTAINED FROM CLINICALLY UNINVOLVED KNEE JOINTS OF PATIENTS WITH RHEUMATOID ARTHRITIS

1989 • 97 citations

Combination treatment of severe rheumatoid arthritis with cyclosporine and methotrexate for forty‐eight weeks. An open‐label extension study

1997 • 96 citations

Combination therapy in rheumatoid arthritis: updated systematic review

1998 • 96 citations

Radiologic evidence of disease modification in rheumatoid arthritis patients treated with cyclosporine. results of a 48‐week multicenter study comparing low‐dose cyclosporine with placebo

1994 • 96 citations

Slow progression of joint damage in early rheumatoid arthritis treated with cyclosporin a

1996 • 85 citations

A randomized, double‐blind, 24‐week controlled study of low‐dose cyclosporine versus chloroquine for early rheumatoid arthritis

1994 • 75 citations

Progression of joint damage in early active severe rheumatoid arthritis during 18 months of treatment: comparison of low-dose cyclosporin and parenteral gold

1998 • 73 citations

Characterization of the synovial T cell response to various recombinantYersiniaantigens inYersinia enterocolitica‐triggered reactive arthritis: Heat‐shock protein 60 drives a major immune response

1998 • 71 citations

Effects of pulse methylprednisolone on cell adhesion molecules in the synovial membrane in rheumatoid arthritis. Reduced E‐selectin and intercellular adhesion molecule 1 expression

1996 • 65 citations

Characterization of the synovial T cell response to various recombinantYersinia antigens inYersinia enterocolitica-triggered reactive arthritis: Heat-shock protein 60 drives a major immune response

1998 • 61 citations

The Dunlop-Dottridge Lecture: prognosis in inflammatory arthritis: the value of HLA genotyping and the oncological analogy.

1997 • 58 citations

The effects of hydrocortisone on in vitro lymphocyte proliferation and interleukin‐2 and ‐4 production in corticosteroid sensitive and resistant subjects

1993 • 55 citations

Subpopulations of primed t helper cells in rheumatoid arthritis

1993 • 50 citations

THE USE OF CYCLOSPORIN A IN RHEUMATOID ARTHRITIS: CONCLUSIONS OF AN INTERNATIONAL REVIEW

1994 • 35 citations

Clinical Use of Cyclosporin in Rheumatoid Arthritis

1995 • 28 citations

Rheumatism in Populations

1978 • 16 citations

How and When Should Combination Therapy be Used? the Role of an Anchor Drug

1995 • 13 citations

Steroid pulse therapy for rheumatoid arthritis: effect on lymphocyte subsets and mononuclear cell adhesion

1998 • 13 citations

How and When Should Combination Therapy be Used? the Role of an Anchor Drug

1995 • 4 citations

Deleted Work

1955 • 0 citations

Cited By (0)

Loading...